Beryl Drugs share news, announcements and annual reports
BSE: 524606Pharmaceuticals & BiotechnologySmall Cap
Beryl Drugs Ltd. · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Sep 1994
Last close ₹25.60up ₹0.60 (2.40%)
Share price at the BSE close on 30 Oct 2026. Previous close ₹25.00.
30 Oct: open ₹27.00, high ₹27.00, low ₹23.00
52-week range of traded prices to 30 Oct 2026
₹15.92Low, 4 Mar 2026₹27.90High, 21 Oct 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹13 Cr4,587th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 20.79
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.31
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 6.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 3.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.24
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 2,166
Beryl Drugs board meetings
153 filed, newest first. Page 3 of 4.
Feb 2020
Nov 2019
12 Nov · Board meeting
6 Nov · Board meeting
Meeting on 12 Nov 2019: quarterly results
Aug 2019
30 Aug · Board meeting
23 Aug · Board meeting
Meeting on 30 Aug 20199 Aug · Board meeting
1 Aug · Board meeting
Meeting on 9 Aug 2019: quarterly results
Jul 2019
May 2019
30 May · Board meeting
22 May · Board meeting
Meeting on 30 May 2019: audited results
Apr 2019
16 Apr · Board meeting
Meeting on 24 Apr 2019
Feb 2019
4 Feb · Board meeting
Meeting on 12 Feb 2019: quarterly results
Nov 2018
13 Nov · Board meeting
Sep 2018
Aug 2018
7 Aug · Board meeting
Jul 2018
May 2018
31 May · Board meeting
Apr 2018
18 Apr · Board meeting
18 Apr · Board meeting
Feb 2018
9 Feb · Board meeting
Nov 2017
4 Nov · Board meeting
Jul 2017
May 2017
30 May · Board meeting
Apr 2017
Feb 2017
Nov 2016
Jul 2016
11 Jul · Board meeting
Board of the Directors of the Company at its meeting held on July 11, 2016, inter alia, has discussed and approved the following: 1. Considered ....
May 2016
Apr 2016
Jan 2016
27 Jan · Board meeting
Board of Directors of the Company at its meeting held on January 27, 2016, inter alia, has considered and approved the following matters:- ....
Dec 2015
14 Dec · Board meeting
Board of Directors of the Company at its meeting held on December 14, 2015, has transacted the following: 1. Considered and approved the ....
Oct 2015
19 Oct · Board meeting
Board of Directors of the Company at its meeting held on October 19, 2015, inter alia, has considered and approved the following matters : ....
Jul 2015
24 Jul · Board meeting
Board of Directors of the Company at its meeting held on July 24, 2015, inter alia, has considered and approved the following: 1. Considered ....
May 2015
31 May · Board meeting
Board of Directors of the Company at its meeting held on May 30, 2015, inter alia, has considered and approved: 1. Considered and approved ....
Apr 2015
20 Apr · Board meeting
Board of Directors of the Company at its meeting held on April 20, 2015, inter alia, has discussed and approved the following: - Took note ....
Feb 2015
20 Feb · Board meeting
Board of Directors of the Company at its meeting held on February 20, 2015, inter alia, has considered and approved following : 1. Delisting ....
Jan 2015
20 Jan · Board meeting
Board of Directors of the Company at its meeting held on January 20, 2015, inter alia, the following decisions were considered and approved: ....
Sep 2014
17 Sep · Board meeting
Board of Directors of the Company at its meeting held on May 30, 2014, inter alia, has not declared any dividend for the year.
May 2014
31 May · Board meeting
Board of Directors of the Company at its meeting held on May 30, 2014, inter alia, has considered and approved the following: 1. Considered ....22 May · Board meeting
Meeting of the Board of Directors of the Company will be held on May 30, 2014, inter alia, to transact the following business: 1. To consider ....